Questcor Pharmaceuticals Inc (QCOR.OQ)

QCOR.OQ on NASDAQ Stock Exchange Global Select Market

69.56USD
1:23pm EDT
Price Change (% chg)

$2.74 (+4.10%)
Prev Close
$66.82
Open
$67.04
Day's High
$69.97
Day's Low
$66.93
Volume
502,885
Avg. Vol
555,572
52-wk High
$69.97
52-wk Low
$17.25

QCOR.OQ

Chart for QCOR.OQ

About

Questcor Pharmaceuticals, Inc. (Questcor) is a biopharmaceutical company. The Company is focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Its primary product is H.P. Acthar Gel (repository corticotropin injection), or Acthar, an injectable drug that is approved by the... (more)

Overall

Beta: 0.77
Market Cap (Mil.): $3,969.88
Shares Outstanding (Mil.): 59.55
Dividend: 0.25
Yield (%): 1.50

Financials

  QCOR.OQ Industry Sector
P/E (TTM): 17.98 37.93 37.76
EPS (TTM): 3.71 -- --
ROI: 84.08 19.48 18.76
ROE: 115.79 20.17 19.59
Search Stocks

Questcor shares touch life-high on strong growth in Acthar sales

- Shares of Questcor Pharmaceuticals Inc rose as much as 26 percent to a life-high on Wednesday, after strong sales growth for Acthar allayed concerns that reimbursement issues would restrict sales for newer uses of the drug.

31 Jul 2013

Questcor profit misses estimates on weak Acthar sales

- Questcor Pharmaceuticals Inc's first-quarter profit lagged analysts' expectations as sales of its Acthar drug fell due to Medicaid reimbursement changes but the company said sales have bounced back in the current quarter.

30 Apr 2013

Questcor 1st-qtr adjusted profit missed estimates

April 30 - Questcor Pharmaceuticals Inc's first-quarter profit missed Street expectations as the number of prescriptions fell for its top-selling drug, Acthar, sending its shares down about 11 percent in after market trade.

30 Apr 2013

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $93.85 +0.35
Pfizer Inc. (PFE.N) $29.05 -0.18
Novartis AG (NOVN.VX) CHF66.60 +0.35
Merck & Co., Inc. (MRK.N) $48.23 +0.06
Roche Holding Ltd. (ROG.VX) CHF228.00 -3.50
Abbott Laboratories (ABT.N) $37.01 +0.38
Bayer AG (BAYGn.DE) €89.43 +2.08
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €76.85 -3.32
GlaxoSmithKline plc (GSK.L) 1,712.50p +28.50

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Factual Report
$127.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks